2020’s

• 2022

  BioActs USA Inc
  BALAMP M MRSA Detection Kit KGMP
  - BioActs USA Inc. (sales branch) established
  - BALAMP M MRSA (Methicillin-resistant Staphylococcus aureus) Detection Kit KGMP approved

• 2021

  - Acquired in vitro diagnostic medical device manufacturing license from Ministry of Food and Drug Safety Busan

• 2020

  CytoFlamma CBC Reagent GMP
  - Acquired medical device manufacturing license in March from Korea Food & Drug Administration and Korea conformity laboratories
  - Certified as a specialized company for material, parts and equipment in June by Korea Evaluation Institute of Industrial Technology
  - CytoFlamma CBC Reagent (whole blood analyzing reagents for flow cytometry) KGMP approved
  - Selected as an intellectual property business corporate

2010’s

• 2019

  Attracted the third round external capital funding.

• 2018

  Established MOU with Korea Atomic Energy Research Institute (KAERI)

• 2017

  Selected as INNOBIZ(innovative technology small company)
  Attracted the second round external capital funding.

• 2016

  Attracted the first round external capital funding.

• 2015

  Change company name to BioActs

• 2014

  Selected as a member of K-club of Korea Institute of Science and Technology.

• 2013

  인천비전기업 선정
  Selected as Incheon Visional Company

• 2012

  Recognized as a Visionary Company by Incheon Metropolitan city.
  Bioengineering, an affiliated institute of NIH.

• 2010

  Certified as an Advanced Technology Center (ATC) for biomolecular labeling materials.
  The New Excellent Technology (NET) certification acquired

2000’s

• 2009

  Biological business division (BioActs) established.

• 2005

  Antibacterial dyes and blue fluorescent OLED material production begin.

• 2002

  Ningbo Factory and Hangzhou Sales Corporation in China launched.

• 2001

  Awarded the presidential commendation and 5 million dollars export tower.

1990’s

• 1991

  Affiliated R&D center established; opened an era of innovative growth.

• 1976

  Corporation established; opened an era of creation and exploration.